Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Netherlands Heart Journal
Published in: Netherlands Heart Journal 5/2017

Open Access 01-05-2017 | Editor’s Comment

The wearable defibrillator: a most affordable vest

Author: J. R. de Groot

Published in: Netherlands Heart Journal | Issue 5/2017

Login to get access

Excerpt

The implantable cardioverter-defibrillator (ICD) has become a cornerstone in the prevention of sudden cardiac death in patients with ischaemic and non-ischaemic cardiomyopathy, as well as in survivors of idiopathic ventricular arrhythmias and carriers of a genetic arrhythmia syndrome. Current guidelines recommend ICD implantation in patients with a left ventricular ejection fraction ≤35%, despite optimal medical treatment for 3 months, and at least 40 days after myocardial infarction or revascularisation [1]. …
Literature
1.
Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;2015(36):2793–867.CrossRef
2.
Lenarczyk R, Potpara TS, Haugaa KH, et al. The use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association survey. Europace. 2016;18:146–50.CrossRefPubMed
3.
Quast AF, van Dijk VF, Wilde AA, et al. Outpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres. Neth Heart J. 2017;25 doi:10.​1007/​s12471-017-0957-4.PubMed
4.
Knops RE, Kooiman KM, Ten Sande JN, et al. First experience with the wearable cardioverter defibrillator in the Netherlands. Neth Heart J. 2012;20:77–81.CrossRefPubMed
5.
Brouwer TF, Yilmaz D, Lindeboom R, et al. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy. JACC. 2016;68:2047–55.CrossRefPubMed
Metadata
Title
The wearable defibrillator: a most affordable vest
Author
J. R. de Groot
Publication date
01-05-2017
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 5/2017
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-017-0980-5

Other articles of this Issue 5/2017

Netherlands Heart Journal 5/2017 Go to the issue

Rhythm Puzzle - Question

Broad complex rhythm with a salty taste

Letter to the Editor

Awareness of resuscitation guidelines in pregnant women

NVVC

NVVC/NHJ Durrer prizes 2016

Letter to the Editor

Improving resuscitation of pregnant women

Original Article - E‑Learning

Gender-based acute outcome in percutaneous coronary intervention of chronic total coronary occlusion

Original Article

Impact of airflow limitation in chronic heart failure